ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,070,329,787 | -10.4% | 39,437,354 | +1.5% | 0.03% | -7.1% |
Q2 2023 | $1,194,181,249 | -12.6% | 38,847,796 | +2.4% | 0.03% | -20.0% |
Q1 2023 | $1,366,618,585 | -2.9% | 37,930,019 | +6.5% | 0.04% | -7.9% |
Q4 2022 | $1,408,010,301 | +0.3% | 35,627,791 | +1.9% | 0.04% | -7.3% |
Q3 2022 | $1,404,364,000 | +1.7% | 34,951,810 | +6.4% | 0.04% | +5.1% |
Q2 2022 | $1,381,172,000 | +11.3% | 32,853,776 | +3.1% | 0.04% | +34.5% |
Q1 2022 | $1,241,289,000 | +5.1% | 31,860,621 | +7.5% | 0.03% | +7.4% |
Q4 2021 | $1,181,017,000 | +8.8% | 29,636,565 | -1.3% | 0.03% | 0.0% |
Q3 2021 | $1,085,216,000 | +8.8% | 30,028,062 | +23.4% | 0.03% | +8.0% |
Q2 2021 | $997,787,000 | +1.6% | 24,342,200 | +8.1% | 0.02% | -7.4% |
Q1 2021 | $981,999,000 | +966.9% | 22,512,593 | +1124.2% | 0.03% | +800.0% |
Q4 2020 | $92,041,000 | +54.8% | 1,838,966 | +30.2% | 0.00% | +50.0% |
Q3 2020 | $59,440,000 | -11.5% | 1,412,886 | +2.1% | 0.00% | 0.0% |
Q2 2020 | $67,162,000 | – | 1,383,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |